Your browser doesn't support javascript.
loading
A Prospective Audit of Intermittent Anti-Androgen verses Pituitary Blockade Suggests a Bipolar Androgen Type Strategy May Be Safe in Untreated Prostate Cancer.
Oliver, Timothy; Wilson, Peter; Ansell, Wendy; Philp, Tim; Chinegwundoh, Frank; Shamash, Jonathan; Shaw, Greg; Ahmad, Amar.
Afiliação
  • Oliver T; Barts Institute of Cancer, Queen Mary University of London, London, United Kingdom.
  • Wilson P; Barts Institute of Cancer, Queen Mary University of London, London, United Kingdom.
  • Ansell W; Barts Institute of Cancer, Queen Mary University of London, London, United Kingdom.
  • Philp T; Department of Urology Whipps Cross University Hospital, London, United Kingdom.
  • Chinegwundoh F; Barts Institute of Cancer, Queen Mary University of London, London, United Kingdom.
  • Shamash J; Barts Institute of Cancer, Queen Mary University of London, London, United Kingdom.
  • Shaw G; Barts Institute of Cancer, Queen Mary University of London, London, United Kingdom.
  • Ahmad A; Wolfson Institute of Preventive Medicine, Queen Mary University of London, and Department of Urology Whipps Cross University Hospital, London, United Kingdom.
Urol Int ; 100(2): 172-180, 2018.
Article em En | MEDLINE | ID: mdl-29275414

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipófise / Neoplasias da Próstata / Protocolos de Quimioterapia Combinada Antineoplásica / Hormônio Liberador de Gonadotropina / Antineoplásicos Hormonais / Antagonistas de Androgênios Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipófise / Neoplasias da Próstata / Protocolos de Quimioterapia Combinada Antineoplásica / Hormônio Liberador de Gonadotropina / Antineoplásicos Hormonais / Antagonistas de Androgênios Idioma: En Ano de publicação: 2018 Tipo de documento: Article